1. Home
  2. FOF vs TKNO Comparison

FOF vs TKNO Comparison

Compare FOF & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOF
  • TKNO
  • Stock Information
  • Founded
  • FOF 2006
  • TKNO 1996
  • Country
  • FOF United States
  • TKNO United States
  • Employees
  • FOF N/A
  • TKNO N/A
  • Industry
  • FOF Investment Managers
  • TKNO Medicinal Chemicals and Botanical Products
  • Sector
  • FOF Finance
  • TKNO Health Care
  • Exchange
  • FOF Nasdaq
  • TKNO Nasdaq
  • Market Cap
  • FOF 354.8M
  • TKNO 256.9M
  • IPO Year
  • FOF N/A
  • TKNO 2021
  • Fundamental
  • Price
  • FOF $13.04
  • TKNO $4.35
  • Analyst Decision
  • FOF
  • TKNO
  • Analyst Count
  • FOF 0
  • TKNO 0
  • Target Price
  • FOF N/A
  • TKNO N/A
  • AVG Volume (30 Days)
  • FOF 58.7K
  • TKNO 224.0K
  • Earning Date
  • FOF 01-01-0001
  • TKNO 08-07-2025
  • Dividend Yield
  • FOF 9.07%
  • TKNO N/A
  • EPS Growth
  • FOF N/A
  • TKNO N/A
  • EPS
  • FOF N/A
  • TKNO N/A
  • Revenue
  • FOF N/A
  • TKNO $38,923,000.00
  • Revenue This Year
  • FOF N/A
  • TKNO $9.52
  • Revenue Next Year
  • FOF N/A
  • TKNO $15.20
  • P/E Ratio
  • FOF N/A
  • TKNO N/A
  • Revenue Growth
  • FOF N/A
  • TKNO 11.40
  • 52 Week Low
  • FOF $9.59
  • TKNO $4.00
  • 52 Week High
  • FOF $11.75
  • TKNO $10.37
  • Technical
  • Relative Strength Index (RSI)
  • FOF 58.11
  • TKNO 43.35
  • Support Level
  • FOF $13.01
  • TKNO $4.22
  • Resistance Level
  • FOF $13.13
  • TKNO $4.94
  • Average True Range (ATR)
  • FOF 0.09
  • TKNO 0.29
  • MACD
  • FOF -0.01
  • TKNO -0.00
  • Stochastic Oscillator
  • FOF 59.05
  • TKNO 16.75

About FOF Cohen & Steers Closed-End Opportunity Fund Inc.

Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: